Korea:087010

Qilu Pharmaceutical and Peptron Sign License Agreement for anti-MUC1 ADC

SEOUL, South Korea and JINAN, China, April 16, 2021 /PRNewswire/ -- Peptron, Inc. ("Peptron", KOSDAQ: 087010), aSouth Korea-based biotech company, and Qilu Pharmaceutical ("Qilu"), a leading vertically integrated pharmaceutical company focused on discovering, developing, manufacturing and commerc...

2021-04-16 20:00 2820